These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37212416)

  • 1. Medication-Related Osteonecrosis of the Jaw.
    Chen YF; Chang HP
    N Engl J Med; 2023 May; 388(21):e69. PubMed ID: 37212416
    [No Abstract]   [Full Text] [Related]  

  • 2. Case report: golimumab-related osteonecrosis of the jaw.
    Ghosh YA; Pullara J; Rattan R; Melville JC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Nov; 136(5):e149-e152. PubMed ID: 37661466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary--Is the bone turnover of the jawbone and its possible over suppression by bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis?
    Carlson ER; Gerard DA
    J Oral Maxillofac Surg; 2014 May; 72(5):911-3. PubMed ID: 24480759
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonates and phossy-jaw: breathing new life into an old problem.
    Ashcroft J
    Lancet Oncol; 2006 Jun; 7(6):447-9. PubMed ID: 16750492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 7. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.
    Campisi G; Mauceri R; Bedogni A; Fusco V
    J Oral Maxillofac Surg; 2022 Nov; 80(11):1723-1724. PubMed ID: 36332990
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonate-induced jaw osteonecrosis--prevention and treatment].
    ; ; ; ;
    Orv Hetil; 2010 Jan; 151(4):148-9. PubMed ID: 20071321
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonate exposure and osteonecrosis of the jaw.
    Hatton RC; Patel P; Liu W
    J Bone Miner Res; 2015 Apr; 30(4):748. PubMed ID: 25808733
    [No Abstract]   [Full Text] [Related]  

  • 13. Bisphosphonate exposure and osteonecrosis of the jaw.
    Borromeo GL; Brand C; Clement JG; McCullough M; Crighton L; Hepworth G; Wark JD
    J Bone Miner Res; 2015 Apr; 30(4):749-50. PubMed ID: 25808734
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication-related osteonecrosis of the jaw; what should we do as prosthodontists?
    Kuroshima S; Kaku M; Matsuura T; Atsuta I; Ayukawa Y; Sawase T
    J Prosthodont Res; 2016 Oct; 60(4):229-230. PubMed ID: 26874926
    [No Abstract]   [Full Text] [Related]  

  • 15. Pembrolizumab related osteonecrosis of the jaw.
    Patel V; Carey B
    Br J Oral Maxillofac Surg; 2023 Dec; 61(10):704-706. PubMed ID: 37957097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Ferneini EM
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1801-1802. PubMed ID: 34334170
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges.
    Schiodt M; Otto S; Fedele S; Bedogni A; Nicolatou-Galitis O; Guggenberger R; Herlofson BB; Ristow O; Kofod T
    Oral Dis; 2019 Oct; 25(7):1815-1821. PubMed ID: 31325201
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis.
    Gavrić M; Antić S; Jelovac DB; Zarev AI; Petrović MB; Golubović M; Antunović M
    Vojnosanit Pregl; 2014 Aug; 71(8):772-6. PubMed ID: 25181838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.